918 results on '"Nobili, Valerio"'
Search Results
2. The Contribution of the Adipose Tissue-Liver Axis in Pediatric Patients with Nonalcoholic Fatty Liver Disease after Laparoscopic Sleeve Gastrectomy
3. Comparison between non-alcoholic fatty liver disease screening guidelines in children and adolescents
4. Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis
5. Prevalence of prediabetes and diabetes in children and adolescents with biopsy-proven non-alcoholic fatty liver disease
6. NAFLD in children: new genes, new diagnostic modalities and new drugs
7. The Role of Genetic Predisposition, Programing During Fetal Life, Family Conditions, and Post-natal Diet in the Development of Pediatric Fatty Liver Disease
8. Evaluations of Lifestyle, Dietary, and Pharmacologic Treatments for Pediatric Nonalcoholic Fatty Liver Disease: A Systematic Review
9. A review of the pathogenic and therapeutic role of nutrition in pediatric nonalcoholic fatty liver disease
10. Pancreatic disorders in children: New clues on the horizon
11. Laparoscopic Sleeve Gastrectomy Improves Nonalcoholic Fatty Liver Disease–Related Liver Damage in Adolescents by Reshaping Cellular Interactions and Hepatic Adipocytokine Production
12. In a pilot study, reduced fatty acid desaturase 1 function was associated with nonalcoholic fatty liver disease and response to treatment in children
13. Nonalcoholic Fatty Liver Disease in Italian Children with Down Syndrome: Prevalence and Correlation with Obesity-Related Features
14. Good adherence to the Mediterranean diet reduces the risk for NASH and diabetes in pediatric patients with obesity: The results of an Italian Study
15. Long-term challenges and perspectives of pre-adolescent liver disease
16. The Benefit of Sleeve Gastrectomy in Obese Adolescents on Nonalcoholic Steatohepatitis and Hepatic Fibrosis
17. Wilson Disease in a Child With Mild Neuropsychiatric and Hepatic Involvement: A Challenging Diagnosis for a Heterogeneous Disorder
18. Reduced lysosomal acid lipase activity – A potential role in the pathogenesis of non alcoholic fatty liver disease in pediatric patients
19. A “systems medicine” approach to the study of non-alcoholic fatty liver disease
20. High concentrations of H2O2 trigger hypertrophic cascade and phosphatase and tensin homologue (PTEN) glutathionylation in H9c2 cardiomyocytes
21. Lipid-Induced Hepatocyte-Derived Extracellular Vesicles Regulate Hepatic Stellate Cells via MicroRNA Targeting Peroxisome Proliferator-Activated Receptor-γ
22. Statin use and non-alcoholic steatohepatitis in at risk individuals
23. Pediatric Intestinal Pseudo-obstruction: Impact of Neonatal and Later Onset on Clinical and Nutritional Outcomes
24. Similarities and Differences in Allocation Policies for Pediatric Liver Transplantation Across the World
25. Nutritional and lipidomics biomarkers of docosahexaenoic acid-based multivitamin therapy in pediatric NASH
26. Beverage consumption and paediatric NAFLD
27. A non-invasive prediction model for non-alcoholic steatohepatitis in paediatric patients with non-alcoholic fatty liver disease
28. Pediatric non-alcoholic fatty liver disease: Recent advances
29. Epidemiology and natural history of NAFLD
30. A practical approach to the child with abnormal liver tests
31. Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity
32. Wilsonʼs Disease in Children: A Position Paper by the Hepatology Committee of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition
33. Pediatric Nonalcoholic Fatty Liver Disease: Current Thinking
34. Hepatic farnesoid X receptor protein level and circulating fibroblast growth factor 19 concentration in children with NAFLD
35. Nonalcoholic Fatty Liver Disease in Children
36. Interferon lambda 4 rs368234815 TT>δG variant is associated with liver damage in patients with nonalcoholic fatty liver disease
37. Early and Late Factors Impacting Patient and Graft Outcome in Pediatric Liver Transplantation: Summary of an ESPGHAN Monothematic Conference
38. Diagnosis, treatment and prevention of pediatric obesity: consensus position statement of the Italian Society for Pediatric Endocrinology and Diabetology and the Italian Society of Pediatrics
39. Mineralization of alpha-1-antitrypsin inclusion bodies in Mmalton alpha-1-antitrypsin deficiency
40. The relationship between body mass index and children’s presentations to a tertiary pediatric emergency department
41. Non-alcoholic fatty liver disease
42. Gut-liver axis and fibrosis in nonalcoholic fatty liver disease: An input for novel therapies
43. Update on lipid species and paediatric nonalcoholic fatty liver disease
44. The Use of Probiotics in Pediatric Nonalcoholic Fatty Liver Disease: Teachable Moment or Missed Opportunity?
45. Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta‐omics‐based approach
46. Nonalcoholic Fatty Liver in Children and Adolescents: An Overview
47. Circulating Soluble Fas and Fas Ligand Levels Are Elevated in Children with Nonalcoholic Steatohepatitis
48. The association between retinal microvascular changes, metabolic risk factors, and liver histology in pediatric patients with non-alcoholic fatty liver disease (NAFLD)
49. Non-alcoholic fatty liver disease in children now: Lifestyle changes and pharmacologic treatments
50. Hepatitis B virus infection in children
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.